Search Results 201-210 of 17403 for Interferon

1. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

   Systemic immunostimulatory agents (including but not limited to interferon and IL-2) within 6 weeks or 5 half-lives of the drug, whichever is shorter, prior to ...

2. Theophylline (oral route) - Side effects & dosage - Mayo Clinic

   Interferon Alfa-2a; Ipriflavone; Isoproterenol; Ketazolam; Loprazolam; Lorazepam; Lormetazepam; Medazepam; Metaclazepam; Methotrexate; Midazolam; Nilutamide ...

3. DISC-3405 In Participants With Polycythemia Vera - Mayo Clinic

   ... interferon-alpha or ruxolitinib with no anticipated need for dose adjustments during the study, or have decreasing dose (with medical monitor approval).

4. Publications - Linda X. Yin, M.D. - Mayo Clinic

   Interferon-gamma Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts. JAMA Otolaryngol Head Neck Surg. 2017 Nov 1; 143 (11):1134-1140. View ...

5. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

   If PPD is not available, then a negative Interferon Gamma Release Assay (IGRA) may be used. The PPD or IGRA test results must be obtained within 90 days ...

6. Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG - Mayo Clinic

   ... interferon). Male or non-pregnant, non-lactating female; Females of childbearing potential and all males with partners of childbearing age only if they agree ...

7. A Study to Evaluate the Effects of Losartan to Reduce Inflammation and Fibrosis Endpoints in Patients with HIV - Mayo Clinic

   Current hepatitis treatments (e.g., interferon, ribavirin) within the past 6 months; Serum potassium > 5.0 millimoles per liter (mmol/L) within 3 months of ...

8. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

   Interleukins, interferons and cytokines (other than hematopoietic growth factors): ≥ 21 days after the completion of interleukins, interferon or cytokines ( ...

9. Polycythemia Vera Clinical Trials - Mayo Clinic Research

   Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) Scottsdale/Phoenix, AZ. The aim of this ...

10. Ruxolitinib Phosphate and Danazol in Treating Anemia in Patients with Myelofibrosis - Mayo Clinic

    ... interferon-alpha), immunosuppressive therapy, corticosteroids > 10 mg/day prednisone or equivalent, or growth factor treatment (e.g., erythropoietin) ...